Filing Flows › Beta Bionics (BBNX) › Recalls, complaints & regulation
Beta Bionics (BBNX): recalls and clinical trials
Beta Bionics (BBNX) beyond its filings: 3 recalls in the last 12 months (3 in five years, 0 Class I); 2 active clinical trials.
Latest recalls
- 2026-06-24 · FDA device · iLet Bionic Pancreas, REF: BB1001
- 2026-05-06 · FDA device · iLet Bionic Pancreas, REF: BB1001
- 2026-04-22 · FDA device · iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software
Beta Bionics' latest quarter
Beta Bionics, Q3 2026: revenue $35.5M (+30% year over year), operating margin -74.9%, net loss $24.4M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
Questions
Has Beta Bionics had any recalls?
3 recalls on file over five years from the FDA, CPSC and NHTSA; 3 in the last 12 months.
How many clinical trials does Beta Bionics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.